Menlo Park, CA, United States of America

James Robert Swartz

USPTO Granted Patents = 52 (Patent Applications = 13)

CIPO Patents = 7 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 10)

Average Co-Inventor Count = 1.9

ph-index = 18

Forward Citations = 1,320(Granted Patents)

Forward Citations (Not Self Cited) = 1,229(Oct 12, 2025)

Inventors with similar research interests:

Location History:

San Mateo, CA (US) (1985)
South San Francisco, CA (US) (2000)
Stanford, CA (US) (2008)
Menlo Park, CA (US) (1994 - 2022)

Company Filing History:

32 out of 5,303

Leland Stanford Junior University

Greenlight Biosciences, Inc.

patents

4. 1 out of 5,444

University of Texas System

patents

5. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2022

Loading Chart...

52 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11261216 - Engineered hepatitis B core polypeptide (2022-03-01),

2. 10948494 - Methods for enumeration of rare cells (2021-03-16),

3. 10221401 - Oxygen tolerant hydrogenase by mutating electron supply pathway (2019-03-05),

4. 10036001 - Recombinant cellular iysate system for producing a product of interest (2018-07-31),

5. 10006062 - Methods for control of flux in metabolic pathways through enzyme relocation (2018-06-26),

6. 9896483 - Stabilized hepatitis B core polypeptides (2018-02-20),

7. 9637522 - Influenza vaccine constructs (2017-05-02),

8. 9611487 - Cell-free system for converting methane into fuel and chemical compounds (2017-04-04),

9. 9550813 - Disulfide stabilized foldon polypeptides (2017-01-24),

10. 9410170 - Methods of in vitro protein synthesis (2016-08-09),

11. 9296792 - Ordered flagellin array as an immunostimulant (2016-03-29),

12. 9255255 - Synthesis of linear and branched polymers of polypeptides through direct conjugation (2016-02-09),

13. 9133486 - Hydrogenase fusion protein for improved hydrogen production (2015-09-15),

14. 8956833 - Methods for control of flux in metabolic pathways through enzyme relocation (2015-02-17),

15. 8916358 - Methods for control of flux in metabolic pathways through protease manipulation (2014-12-23),

Title: James Robert Swartz: Innovator in Biotech Solutions

Introduction

James Robert Swartz is a notable inventor residing in Menlo Park, California. With an impressive portfolio of 51 patents, he has significantly contributed to the field of biotechnology. His work focuses on advanced methods and compositions, particularly in the analysis of biological entities.

Latest Patents

Among his recent innovations are two distinguished patents:

1. **Engineered Hepatitis B Core Polypeptide** - This patent involves genetically modified HBc polypeptides, providing novel solutions to hepatitis B research.

2. **Methods for Enumeration of Rare Cells** - This patent presents methods for analyzing rare cells or other biological entities. It details techniques for contacting populations with a labeling nanoparticle that includes a virus-like particle (VLP) conjugated to a light-emitting moiety, facilitating detection through light emission.

Career Highlights

James has worked with renowned institutions throughout his career, including Leland Stanford Junior University and Genentech, Inc. His role in these organizations has allowed him to pioneer significant advancements in biotechnological research.

Collaborations

Throughout his career, James has collaborated with notable colleagues, such as Woon-Lam Susan Leung and Dong-Myung Kim. Their collective efforts have enhanced the depth and breadth of innovations in the biotech sector.

Conclusion

James Robert Swartz remains a pivotal figure in the biotechnology arena, with a promising portfolio of patents that reflect his dedication to innovation. His work continues to be influential in the development of new methodologies and applications within the field, contributing to advancements in science and technology.

This text is generated by artificial intelligence and may not be accurate.